Active Ingredient: LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Proprietary Name: LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG;200MG;300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N205626
Product Number: 001
Approval Date: Aug 13, 2018
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
